Barbados vs Senegal: Access to anti-retroviral drugs, male
Barbados
57.0%
in 2024
Senegal
56.0%
in 2024
Barbados rank
109th
Senegal rank
110th
Access to anti-retroviral drugs, male over time
- Barbados
- Senegal
How they compare
Barbados currently reports 57.0% against 56.0% in Senegal, a difference of 1.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Senegal ahead.
Barbados ranks 109th and Senegal ranks 110th of 141 countries.
Barbados has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Barbados | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 17.7% | 4.0% | 13.7% | Barbados |
| 2010s | 44.9% | 30.8% | 14.1% | Barbados |
| 2020s | 54.4% | 53.4% | 1.0% | Barbados |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Barbados or Senegal?
- Barbados, at 57.0% against 56.0% in Senegal as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Barbados and Senegal?
- 1.0%, with Barbados ahead.
- How many years of comparable data are there for Barbados and Senegal?
- 25 years are reported by both, from 2000 to 2024.
- How do Barbados and Senegal rank globally for access to anti-retroviral drugs, male?
- Barbados ranks 109th and Senegal ranks 110th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.